Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Analytical Chemistry|April 17, 2025
Digitally Assisted Single-Particle Tracking for Accurate Analysis of Complicated Cargo Transport Dynamics in Microtubule NetworksXiaodong Cheng, Xiaojuan Cheng, Riyang Huang, et al.Molecular Plant|December 19, 2017
Shortened Basal Internodes Encodes a Gibberellin 2-Oxidase and Contributes to Lodging Resistance in RiceChang Liu, Shuai Zheng, Jinshan Gui, et al.Journal of the American Chemical Society|May 30, 2026
Single-Molecule Visualization of Nanoscale Spatiotemporal Dynamics of Charge-Carrier-Driven Photocatalysis on 2D InSeLi Zuo, Ran Zhang, Keng Chen, et al.RSC Medicinal Chemistry|May 8, 2025
Discovery of novel antimyeloma agents targeting TRIP13 by molecular modeling and bioassaySamuel Jacob Bunu, Haiyan Cai, Zhaoyin Zhou, et al.Life Sciences|January 12, 2020
Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathwaysWan He, Zhijian Xu, Dongliang Song, et al.Cancer Medicine|November 9, 2023
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damageShuaikang Chang, Wenqin Xiao, Yongsheng Xie, et al.Acta Biochimica Et Biophysica Sinica|April 8, 2020
Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cellsMengyu Xi, Wan He, Bo Li, et al.Oncotarget|February 4, 2017
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myelomaYi Tao, Guang Yang, Hongxing Yang, et al.Acta Biochimica Et Biophysica Sinica|February 23, 2023
A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathwayBibo Zhang, Bo Li, Yongsheng Xie, et al.Translational Oncology|November 15, 2025
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myelomaLi Xu, Hui Zhang, Kai Wang, et al.Pageof 5